<DOC>
	<DOCNO>NCT01043276</DOCNO>
	<brief_summary>The purpose study investiagte time course PF-00258210 plasma concentration presence absence PF-00610335 administer via oral inhalation use dry powder inhaler</brief_summary>
	<brief_title>A Study To Estimate The Relative Bioavailability Of PF-00258210 Administered Alone Or In Combination With PF-00610355</brief_title>
	<detailed_description />
	<criteria>Healthy male and/or female subject age 21 55 year , inclusive Body Mass Index ( BMI ) 17.5 30.5 kg/m2 ; total body weight &gt; 50 kg ( 110 lb ) Evidence history clinically significant hematological , renal , endocrine , pulmonary , gastrointestinal , cardiovascular , hepatic , psychiatric , neurologic , allergic disease ( include drug allergy , exclude untreated , asymptomatic , seasonal allergy time dose ) A positive urine drug screen Pregnant nursing female</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Healthy</keyword>
</DOC>